Write the management of Hypertensive crisis."

Reading File
Finding Sources
Finding Sources
Searching PubMed

"hypertensive emergency" AND management

Searching Images

hypertensive emergency management algorithm target organ damage

Reading File
Reading File

Management of Hypertensive Crisis

1. Definitions and Classification

Hypertensive crisis is severe blood pressure elevation (generally systolic ≥180 mmHg and/or diastolic ≥110-120 mmHg) and is divided into two categories based on presence or absence of acute target-organ damage (TOD), not on the BP number alone:
  • Hypertensive urgency: Severely elevated BP without acute TOD. Symptoms like headache, epistaxis, or dizziness alone do not qualify as an emergency and do not mandate acute BP lowering (Symptom to Diagnosis, 4th ed.; ROSEN's Emergency Medicine, p. 2396).
  • Hypertensive emergency: Severely elevated BP with acute TOD involving the brain, heart, kidneys, or vasculature. This is defined by the organ injured, not the absolute BP value (ROSEN's Emergency Medicine, p. 2401).
Approximate distribution of target-organ involvement in hypertensive emergencies (ROSEN's Emergency Medicine, Table 70.3, p. 2406):
OrganPresentationIncidence
HeartAcute heart failure, acute coronary syndrome27-49%
BrainIschemic stroke, intracranial hemorrhage, hypertensive encephalopathy37-45%
KidneyAcute kidney injury~15%
VascularAortic dissection1-2%
OtherEclampsia, hypertensive retinopathy1-2%

2. General Principles

  • Admit true hypertensive emergencies to an ICU/monitored setting for continuous BP monitoring and titratable IV therapy.
  • Use short-acting, titratable IV agents (nicardipine, clevidipine, labetalol, nitroprusside, nitroglycerin, esmolol) rather than oral agents.
  • Rate of reduction matters more than the absolute target. General rule: lower mean arterial pressure (MAP) by no more than 20-25% within the first 1-2 hours, then gradually normalize over 24-48 hours (Lippincott Illustrated Reviews Pharmacology, p. 4417; Goldman-Cecil Medicine, p. 471-472). Overly aggressive lowering risks hypoperfusion/ischemic injury to organs that have adapted their autoregulation to chronically elevated pressures - especially the brain (watershed ischemia) and kidneys.
  • Hypertensive urgency is managed with oral agents and close outpatient/ED follow-up over 24-48 hours; rapid, aggressive BP lowering is not indicated and can cause harm (Symptom to Diagnosis, p. 5798-5814).

3. Organ-Specific (Compelling-Indication) Management

From Goldman-Cecil Medicine (Table 39-1, p. 471-472) - the treatment is tailored to the organ injured:
PresentationTimeline / TargetPreferred AgentAlternative
Malignant hypertension ± thrombotic microangiopathy/AKIHours; MAP ↓20-25%Labetalol or nicardipineNitroprusside
Hypertensive encephalopathyImmediate; MAP ↓20-25%Labetalol or nicardipineNitroprusside
Acute ischemic stroke, BP >220/120 (not for thrombolysis)1 hr; MAP ↓15%Labetalol or nicardipineNitroprusside
Acute ischemic stroke, candidate for thrombolysis, BP >185/1101 hr; MAP ↓15%Labetalol or nicardipineNitroprusside
Acute hemorrhagic stroke, SBP >180Immediate; SBP 130-180Labetalol or nicardipineUrapidil
Acute coronary syndromeImmediate; SBP <140Nitroglycerin or labetalolUrapidil
Acute cardiogenic pulmonary edemaImmediate; SBP <140Nitroprusside or nitroglycerin + loop diureticUrapidil + loop diuretic
Acute aortic dissectionImmediate; SBP <120 and HR <60Esmolol PLUS nitroprusside/nitroglycerin or nicardipineLabetalol or metoprolol
Eclampsia/severe preeclampsia/HELLPImmediate; SBP <160Labetalol, hydralazine, or nicardipine (plus magnesium sulfate for seizure prophylaxis)-
Key pharmacologic notes:
  • Nitroprusside obliterates cerebral autoregulation and is avoided in intracranial hemorrhage/stroke; nicardipine is preferred in that setting (Comprehensive Clinical Nephrology, 7th ed., p. 2889-2893).
  • Aortic dissection always requires a beta-blocker (esmolol/labetalol) before or with a vasodilator to blunt reflex tachycardia and shear stress; vasodilator monotherapy is contraindicated because it can increase dP/dt and propagate the dissection.
  • Pheochromocytoma crisis: phentolamine (alpha-blockade) is preferred; beta-blockers should not be given before adequate alpha-blockade (risk of unopposed alpha-agonism and paradoxical BP rise).
  • Pregnancy/eclampsia: nitroprusside and ACE inhibitors/ARBs are avoided (fetal toxicity); labetalol, hydralazine, or nicardipine plus magnesium sulfate are used.

4. Diagnostic Workup (parallel to initiating therapy)

  • Focused history/exam for neurologic deficits, chest/back pain, dyspnea, visual changes, pregnancy status.
  • Fundoscopy (papilledema, hemorrhages, exudates), ECG, troponin, BUN/creatinine, urinalysis (proteinuria/hematuria), CBC with peripheral smear (schistocytes suggest thrombotic microangiopathy), CT/MRI brain if neurologic signs, CXR/CT chest if dissection suspected.

5. Recent Literature

Current reviews reinforce this approach - individualized targets based on the specific end-organ syndrome, cautious/graded BP reduction, and preference for IV nicardipine, clevidipine, or labetalol over nitroprusside in most scenarios given nitroprusside's cyanide toxicity risk and unfavorable cerebral hemodynamics:
  • Miller JB et al., "Evaluation and management of hypertensive emergency," BMJ 2024 (PMID: 39059997)
  • Jolly H et al., "Management of hypertensive emergencies and urgencies: narrative review," Postgrad Med J 2023 (PMID: 37222066)
  • Farley TM, "Hypertensive Emergency: Parenteral Antihypertensives and Population Data," Curr Hypertens Rep 2023 (PMID: 37975973)
No results contradicted the textbook-based approach above; they largely affirm it with updated drug-comparison data.
This is a shared conversation. Sign in to Orris to start your own chat.